Nadia Naldi

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ <i>neu</i> –Positive Metastatic Breast Cancer

Antonino Musolino, Nadia Naldi, Beatrice Bortesi et al. · Journal of Clinical Oncology · 2008 · 949 citations · Full text

Large scale multifactorial likelihood quantitative analysis of <i>BRCA1</i> and <i>BRCA2</i> variants: An ENIGMA resource to support clinical variant classification

Michael T. Parsons, Emma Tudini, Hongyan Li et al. · Human Mutation · 2019 · 148 citations · Full text

Genetics, Genetic Epidemiology, Pathology +25

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study

Antonino Musolino, Maria Angela Bella, Beatrice Bortesi et al. · The Breast · 2007 · 130 citations

Breast Oncology, Somatic Variant, Molecular Markers +9

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines

Silvia La Monica, Daniele Cretella, Mara Bonelli et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 89 citations · Full text

Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR- Activating Mutation

Silvia La Monica, Denise Madeddu, Marcello Tiseo et al. · Journal of Thoracic Oncology · 2016 · 78 citations

Signal Transduction, Signaling Pathway, Receptor Tyrosine Kinase +7